what is a glucagon like peptide GLP-1 is a gut-derived peptide secreted from intestinal L-cells - GLP-1 GLP-1 is a gut-derived peptide secreted from intestinal L-cells What is a Glucagon-Like Peptide? Understanding its Role in Health and Medicine

Glucagon-like peptide-1 vsglucagon Glucagon-like peptide-1 (GLP-1), often referred to simply as GLP-1, is a fascinating and increasingly important peptide hormone with significant implications for metabolic health and therapeutic interventions3天前—GLP-1 stands forglucagon-like peptide-1, a hormone released by the intestines after eating. This hormone plays an important role in: ...GLP-1 .... This naturally occurring substance, predominantly produced in the gut, plays a crucial role in regulating blood sugar levels and influencing appetiteGlucagon-Like Peptide-1 (GLP-1), human. Understanding what is a glucagon-like peptide involves delving into its origins, functions, and its growing presence in modern medicine, particularly in the treatment of conditions like type 2 diabetes and obesity.Diabetes medicines: GLP-1 agonists - Overview

The Origins and Nature of Glucagon-Like Peptide-1

Glucagon-like peptide (GLP-1) is a 30-amino acid peptide hormone that originates from the proglucagon precursor molecule. Its production is primarily carried out by specialized cells in the intestinal lining known as enteroendocrine L-cells, located in both the small and large intestine. The secretion of GLP-1 is intimately linked to nutrient intake; it is released from intestinal L-cells after a meal, acting as a signal that digestion and absorption are underway.

While GLP-1 is a distinct entity, it's important to note its nomenclature.The physiology of glucagon-like peptide 1 The term "glucagon-like peptide" arises from its structural similarity to glucagon, another hormone involved in glucose regulationGlucagon-like peptide-1 receptor agonists for obesity. However, their physiological actions differ significantly. GLP-1 itself is a multifaceted hormone with broad pharmacological potential. The molecule can exist as a peptide of 36 or 37 amino acids depending on its processing.

Key Functions of Glucagon-Like Peptide-1

The physiological actions of GLP-1 are diverse and critical for maintaining metabolic balance. One of its primary roles is as an incretin hormone.Glucagon-like peptide 1 (GLP-1) - PMC Incretins are gut hormones that are released after a meal and enhance the secretion of insulin from the pancreas in a glucose-dependent manner. This means that GLP-1 stimulates glucose-dependent insulin release from the pancreatic islets, helping to lower blood sugar levels after eating.2025年12月1日—WHO defines obesity as having a Body Mass Index (BMI) of 30 or higher in adults.GLP-1 receptor agonists are a class of medicines that help ...

Beyond its effects on insulin, GLP-1 also influences other aspects of glucose homeostasis:

* Inhibition of Glucagon Secretion: GLP-1 acts to suppress the release of glucagon, a hormone that raises blood sugar. This further contributes to preventing hyperglycemia (high blood sugar).

* Slowing Gastric Emptying: The hormone slows gastric emptying, which means food stays in the stomach longer. This effect contributes to a feeling of fullness and can help moderate the post-meal rise in blood glucose.

* Appetite Regulation: GLP-1 plays a significant role in appetite control. It acts on the brain to reduce food intake and promote satiety, contributing to weight management. This is why GLP-1 medicines reduce food intake, body weight, insulin resistance and inflammation.

GLP-1 in Therapeutic Applications

The profound effects of GLP-1 on glucose control and weight have led to the development of a significant class of medications known as GLP-1 agonists or GLP-1 receptor agonists (GLP-1 RAs). These medications are designed to mimic or enhance the actions of the naturally occurring GLP-1.

Initially developed to treat type 2 diabetes, GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes.What Happens When You Stop Taking a GLP-1 Drug? They are highly effective in improving glycemic control through their insulin-stimulating and glucagon-suppressing effects2025年12月1日—WHO defines obesity as having a Body Mass Index (BMI) of 30 or higher in adults.GLP-1 receptor agonists are a class of medicines that help ....

More recently, the weight-reducing properties of GLP-1 (glucagon-like peptide-1) medications have gained widespread attention. These drugs have proven to be highly effective for weight loss, leading to their use in treating obesity. The World Health Organization (WHO) defines obesity as having a Body Mass Index (BMI) of 30 or higher in adults, and GLP-1 receptor agonists are a class of medicines that help manage this conditionFDA Requests Removal of Suicidal Behavior and Ideation ....

It's important for individuals considering or using these medications to be aware of potential side effects.3天前—GLP-1 RAs are peptide moleculesthat cannot yet be effectively absorbed through transdermal delivery systems, and microdosing has not been ... While GLP-1 drugs for diabetes and weight loss have proven to be very effective, they do have side effects.Minireview: The Glucagon-Like Peptides - Oxford Academic Among these are reported effects on facial appearance, sometimes referred to as "Ozempic face." Furthermore, stopping these medications can lead to weight regain for many individuals, and going off a GLP-1 — short for glucagon-like peptide-1 receptor agonist — isn't without potential consequences.

Future Directions and Research

The field of glucagon-like peptide-1 research continues to expand. Scientists are exploring new therapeutic applications, optimizing existing treatments, and investigating ways to activate GLP-1 naturally. While GLP-1 RAs are peptide molecules and their administration typically involves injections, research is ongoing into alternative delivery methods. The understanding of glucagon-like peptide-1 function is constantly evolving, promising further advancements in metabolic disease managementGlucagon-Like Peptide 1 Secretion by the L-Cell | Diabetes. The comprehensive role of GLP-1 as a hormone and neurotransmitter highlights its importance in overall health, making it a key area of ongoing scientific inquiry.